BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kheir F, Cheng G, Rivera E, Folch A, Folch E, Fernandez-Bussy S, Keyes C, Parikh M, Channick C, Chee A, Majid A. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection. J Bronchology Interv Pulmonol 2018;25:125-31. [PMID: 29346247 DOI: 10.1097/LBR.0000000000000461] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Karandashova S, Florova G, Idell S, Komissarov AA. From Bedside to the Bench—A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema. Front Pharmacol 2022;12:806393. [DOI: 10.3389/fphar.2021.806393] [Reference Citation Analysis]
2 Lau EP, Eshraghi M, Dootson K, Yeoh C, Ywe Phu W, Lee YG, Popowicz ND. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection. ERJ Open Res 2022;8:00590-2021. [DOI: 10.1183/23120541.00590-2021] [Reference Citation Analysis]
3 Hassan M, Patel S, Sadaka AS, Bedawi EO, Corcoran JP, Porcel JM. Recent Insights into the Management of Pleural Infection. Int J Gen Med 2021;14:3415-29. [PMID: 34290522 DOI: 10.2147/IJGM.S292705] [Reference Citation Analysis]
4 Chong WH, Hu K, Saha BK, Chopra A. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis. Pulm Pharmacol Ther 2021;71:102081. [PMID: 34571093 DOI: 10.1016/j.pupt.2021.102081] [Reference Citation Analysis]